Physician profile
Renae Springer
NPI 1225501406
$1,189.02
in general payments reported to CMS, 2019-2025
15 companies · $313 in 2025
The $313 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $76.94 · 2023: $318 · 2024: $481 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,112.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $197.62 | 2023-2024 | Cuvitru, Eohilia |
| Inspire Medical Systems, INC. | $179.60 | 2023-2025 | Inspire |
| Octapharma USA, INC. | $154.68 | 2024 | Cutaquig |
| Regeneron Healthcare Solutions, INC. | $140.87 | 2023-2025 | Dupixent |
| Genzyme Corporation | $133.43 | 2023-2025 | |
| Optinose US, INC. | $120.69 | 2022-2025 | |
| Glaxosmithkline, LLC. | $60.09 | 2025 | Nucala |
| Medtronic, INC. | $45.25 | 2023 | Propel |
| Stryker Corporation | $38.29 | 2024 | Clarifix Cryotherapy Device |
| Pharming Healthcare, INC. | $24.56 | 2022 | |
| Genentech USA, INC. | $21.04 | 2024 | Xolair |
| Amgen INC. | $20.94 | 2022 | |
| Csl Behring | $20.77 | 2023 | Hizentra |
| Kowa Pharmaceuticals America, INC. | $16.91 | 2023 | Seglentis |
| Phadia US INC. | $14.28 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renae Springer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.